Gengos Andrew

Terns Pharmaceuticals, Inc. · Chief Financial Officer

Gengos Andrew is listed in public filings as officer: Chief Financial Officer. This Gengos Andrew insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Terns Pharmaceuticals, Inc. (TERN), and LeonaBio, Inc. (LONA). Investors use Gengos Andrew's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Terns Pharmaceuticals, Inc.TERN$20k5k sharesBuyJun 27, 2025$3.93--
Terns Pharmaceuticals, Inc.TERN$20k5k sharesBuyJun 27, 2025$3.93--